H. Mateos-Toledo

发表

Rheumatoid arthritis-related interstitial lung disease (RA-ILD): methotrexate and the severity of lung disease are associated to prognosis

M. Mejía, J. Rojas-Serrano, Denisse Herrera-Bringas, 2017, Clinical Rheumatology.

Evolution of Pulmonary Function in a Cohort of Patients with Interstitial Lung Disease and Positive for Antisynthetase Antibodies

M. Mejía, I. Buendía-Roldán, J. Rojas-Serrano, 2020, The Journal of Rheumatology.

Methotrexate and Lung Disease in Rheumatoid Arthritis: Comment on the Article by Conway et al

M. Mejía, J. Rojas-Serrano, H. Mateos-Toledo, 2014, Arthritis & rheumatology.

Rheumatoid arthritis-related interstitial lung disease (RA-ILD): a possible association between disease activity and prognosis

M. Mejía, J. Rojas-Serrano, Denisse Herrera-Bringas, 2022, Clinical Rheumatology.

Prognostic factors in a cohort of antisynthetase syndrome (ASS): serologic profile is associated with mortality in patients with interstitial lung disease (ILD)

M. Mejía, J. Rojas-Serrano, Denisse Herrera-Bringas, 2015, Clinical Rheumatology.

Rheumatoid arthritis-associated interstitial lung disease: lung inflammation evaluated with high resolution computed tomography scan is correlated to rheumatoid arthritis disease activity.

M. Mejía, J. Rojas-Serrano, Renzo Pérez-Dórame, 2015, Reumatologia clinica.

Anti-Aminoacyl Transfer-RNA-Synthetases (Anti-tRNA) Autoantibodies Associated with Interstitial Lung Disease: Pulmonary Disease Progression has a Persistent Elevation of the Th17 Cytokine Profile

M. Mejía, I. Buendía-Roldán, H. Mateos-Toledo, 2020, Journal of clinical medicine.

Pulmonary Involvement in Systemic Vasculitis

M. Alba, H. Mateos-Toledo, L. Flores-Suárez, 2017, Current Rheumatology Reports.

Hemorragia alveolar difusa: frecuencia, causa y desenlace

H. Mateos-Toledo, J. Rodríguez-Chagolla, M. Y. Valdespino-Vázquez, 2016 .

Interstitial lung disease progression in patients with Anti-aminoacyl Transfer-RNA-Synthetase Autoantibodies is characterized by higher levels of sCD163.

M. Mejía, I. Buendía-Roldán, J. Rojas-Serrano, 2022, Immunology letters.

Early interstitial lung disease in microscopic polyangiitis: Case report and literature review.

H. Mateos-Toledo, E. Estrada-Castro, Marcos García-Nava, 2017, Reumatologia clinica.

An Open-label Study With Pirfenidone on Chronic Hypersensitivity Pneumonitis

M. Gaxiola, A. Estrada, I. Buendía-Roldán, 2020, Archivos de Bronconeumología (English Edition).

An Open-label Study With Pirfenidone on Chronic Hypersensitivity Pneumonitis.

M. Gaxiola, A. Estrada, M. Selman, 2019, Archivos de bronconeumologia.

Enhanced Activity of NLRP3 Inflammasome in the Lung of Patients with Anti-Synthetase Syndrome

M. Mejía, W. Andrade, I. Buendía-Roldán, 2022, Cells.

Interstitial lung disease and myositis-specific and associated autoantibodies: Clinical manifestations, survival and the performance of the new ATS/ERS criteria for interstitial pneumonia with autoimmune features (IPAF).

M. Mejía, J. Rojas-Serrano, Denisse Herrera-Bringas, 2017, Respiratory medicine.

Acoustic evaluation of pirfenidone on patients with combined pulmonary fibrosis emphysema syndrome

Norma Castañeda-Villa, Ramón González-Camarena, Tomás Aljama-Corrales, 2016, 2016 38th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC).

Clinical risk factors in patients with interstitial lung disease associated with anti-MDA5 autoantibodies.

M. Mejía, I. Buendía-Roldán, H. Mateos-Toledo, 2023, Medicina clinica.

A multichannel acoustic approach to define a pulmonary pathology as combined pulmonary fibrosis and emphysema syndrome

Sonia Charleston-Villalobos, Ramón González-Camarena, Tomás Aljama-Corrales, 2017, 2017 39th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC).